Emtricitabine and tenofovir alafenamide (TAF) tablets as PrEP

Provenance

Developed by SPS, NHS England, the British Association for Sexual Health and HIV (BASHH), the British HIV Association (BHIVA) and the support of specialist stakeholders working within clinical practice for sexual health services.

Scope

This PGD applies to the supply of emtricitabine/tenofovir alafenamide fumarate (TAF) as Pre-Exposure Prophylaxis (PrEP) for the prevention of sexually transmitted HIV infection in line with NHSE commissioning policy and in line with the product licence.

PGD template attachment

The template PGD is attached below to download and use in conjunction with our implementation advice (SPS page).

• TAF-FTC Pre-Exposure Prophylaxis PrEP National PGD template V1.0Opens in a new window · Word · 89 KB

More sexual health PGD templates

• Emtricitabine and tenofovir disoproxil (TD) tablets as PrEP
• Doxycycline for use within sexual health services
• Azithromycin (oral) for use within sexual health services
• Ceftriaxone intramuscular injection for Neisseria gonorrhoeae
• Metronidazole (oral) for use within sexual health services
• Doxycycline post exposure prophylaxis (doxyPEP)
• Emtricitabine/tenofovir and raltegravir tablets for HIV PEP
• Podophyllotoxin (topical) for external anogenital warts
• Imiquimod 5% w/w cream for anogenital warts
• Aciclovir (oral) for genital HSV infection
• Fluconazole 150mg capsules for candidiasis
• Clotrimazole cream for candidiasis and candidal balanoposthitis
• Clotrimazole pessaries for candidiasis

All PGD templates

Update history